Multiplexed serology in atypical bacterial pneumonia

Annals of the New York Academy of Sciences

Volumn 1078, Issue , 2006, Pages 530-540

  Gouriet, Frédérique ^a,b   Drancourt, Michel ^a   Raoult, Didier ^a,c  

^a CNRS   (France)

^b INODIAG   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Chlamydia pneumoniae; Chlamydia psittaci; Coxiella burnetii; Francisella tularensis; Immunofluescence; Legionella sp.; Multiplexed serology; Mycoplasma pneumoniae

Indexed keywords

BACTERIAL PNEUMONIA; BACTERIUM DETECTION; CLINICAL FEATURE; CONFERENCE PAPER; COXIELLA BURNETII; DNA MICROARRAY; FRANCISELLA TULARENSIS; LABORATORY DIAGNOSIS; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIA; NONHUMAN; PROTEIN MICROARRAY; SEROLOGY; VIRUS PNEUMONIA;

BACTERIA (MICROORGANISMS); CHLAMYDIA SP.; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; COXIELLA BURNETII; FRANCISELLA TULARENSIS; LEGIONELLA SP.; MYCOPLASMA PNEUMONIAE;

EID: 33845704176     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1374.104     Document Type: Conference Paper

References (33)

1. MANDELL, L.A., T.J. MARRIE, R.F. GROSSMAN, et al. 2000. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin. Infect. Dis. 31: 383-421.
2. RUIZ, M., S. EWIG, A. TORRES, et al. 1999. Severe community-acquired pneumonia: risk factors and follow-up epidemiology. Am. J. Resp. Crit. Care Med. 160: 923-929.
3. MARRIE, T.J., H. DURANT & L. YATES. 1989. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev. Infect. Dis. 11: 586-599.
4. MARRIE, T.J., D. RAOULT, B. LA SCOLA, et al. 2001. Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. Emerg. Infect. Dis. 7: 1026-1029.
5. LIU, W.T., A.D. MIRZABEKOV & D.A. STAHL. 2001. Optimization of an oligonucleotide microchip for microbial identification studies: a non-equilibrium dissociation approach. Environ. Microbiol. 3: 619-629.
6. BORISKIN, Y.S., P.S. RICE, R.A. STABLER, et al. 2004. DNA microarrays for virus detection in cases of central nervous system infection. J. Clin. Microbiol. 42: 5811-5818.
7. BODROSSY, L. & A. SESSITSCH. 2004. Oligonucleotide microarrays in microbial diagnostics. Curr. Opin. Microbiol. 7: 245-254.
8. BELOSLUDTSEV, Y.Y., D. BOWERMAN, R. WEIL, et al. 2004. Organism identification using a genome sequence-independent universal microarray probe set. Biotechniques 37: 654-658, 660.
9. MARRIE, T.J., R.W. PEELING, M.J. FINE, et al. 1996. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am. J. Med. 101: 508-515.
10. FOY, H.M. 1993. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 17 (Suppl. 1): S37-S46.
11. CLYDE, W.A., JR. 1993. Clinical overview of typical Mycoplasma pneumoniae infections. Clin. Infect. Dis. 17 (Suppl. 1): S32-S36.
12. ALEXANDER, T.S., L.D. GRAY, J.A. KRAFT, et al. 1996. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J. Clin. Microbiol. 34: 1180-1183.
13. KAUPPINEN, M. & P. SAIKKU. 1995. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin. Infect. Dis. 21 (Suppl. 3): S244-S252.
14. PEELING, R.W. & R.C. BRUNHAM. 1996. Chlamydiae as pathogens: new species and new issues. Emerg. Infect. Dis. 2: 307-319.
15. KUO, C.C., L.A. JACKSON, L.A. CAMPBELL & J.T. GRAYSTON. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8: 451-461.
16. EKMAN, M.R., M. LEINONEN, H. SYRJALA, et al. 1993. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur. J. Clin. Microbiol. Infect. Dis. 12: 756-760.
17. WONG, K.H., S.K. SKELTON & H. DAUGHARTY. 1994. Utility of complement fixation and microimmunofluorescence assays for detecting serologic responses in patients with clinically diagnosed psittacosis. J. Clin. Microbiol. 32: 2417-2421.
18. MARRIE, T.J. 2003. Coxiella burnetii pneumonia. Eur. Respir. J. 21: 713-719.
19. DUPONT, H.T., X. THIRION & D. RAOULT. 1994. Q fever serology: cutoff determination for microimmunofluorescence. Clin. Diagn. Lab. Immunol. 1: 189-196.
20. FOURNIER, P.E., T.J. MARRIE & D. RAOULT. 1998. Diagnosis of Q fever. J. Clin. Microbiol. 36: 1823-1834.
21. FENOLLAR, F., P.E. FOURNIER & D. RAOULT. 2004. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J. Clin. Microbiol. 42: 4919-4924.
22. WILKINSON, H.W., A.L. REINGOLD, B.J. BRAKE, et al. 1983. Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J. Infect. Dis. 147: 23-31.
23. SATO, T., H. FUJITA, Y. OHARA & M. HOMMA. 1990. Microagglutination test for early and specific serodiagnosis of tularemia. J. Clin. Microbiol. 28: 2372-2374.
24. VILJANEN, M.K., T. NURMI & A. SALMINEN. 1983. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. J. Infect. Dis. 148: 715-720.
25. HERMANN, C., K. GUEINZIUS, A. OEHME, et al. 2004. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J. Clin. Microbiol. 42: 2476-2479.
26. WAITES, K.B. & D.F. TALKINGTON. 2004. Mycoplasma pneumoniae and its role as a human pathogen [table]. Clin. Microbiol. Rev. 17: 697-728.
27. MITTERER, G., M. HUBER, E. LEIDINGER, et al. 2004. Microarray-based identification of bacteria in clinical samples by solid-phase PCR amplification of 23 S ribosomal DNA sequences. J. Clin. Microbiol. 42: 1048-1057.
28. WILTSHIRE, S., S. O'MALLEY, J. LAMBERT, et al. 2000. Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin. Chem. 46: 1990-1993.
29. HAAB, B.B. 2001. Advances in protein microarray technology for protein expression and interaction profiling. Curr. Opin. Drug Discov. Dev. 4: 116-123.
30. HUANG, R.P., R. HUANG, Y. FAN & Y. LIN. 2001. Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal. Biochem. 294: 55-62.
31. MEZZASOMA, L., T. BACARESE-HAMILTON, M. DI CRISTINA, et al. 2002. Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48: 121-130.
32. BACARESE-HAMILTON, T., L. MEZZASOMA, A. ARDIZZONI, et al. 2004. Serodiagnosis of infectious diseases with antigen microarrays. J. Appl. Microbiol. 96: 10-17.
33. BIAGINI, R.E., D.L. SAMMONS, J.P. SMITH, et al. 2005. Simultaneous measurement of specific serum IgG responses to five select agents. Anal. Bioanal. Chem. 382: 1027-1034.